Novartis is a multinational pharmaceutical company that operates in several divisions, including pharmaceuticals, generics, eye care, and vaccines. One of its most significant divisions is its pharmaceuticals division, which develops and markets innovative drugs to treat a wide range of diseases and conditions, such as cancer, cardiovascular disease, multiple sclerosis, and respiratory diseases.
Novartis pharmaceuticals division is known for its commitment to developing new treatments through cutting-edge research and development. It has a strong pipeline of drugs in various stages of development, with a focus on oncology, immunology, neuroscience, and dermatology.
In addition to its drug development efforts, Novartis also offers a range of patient support programs and services to help improve patient outcomes and access to treatments. These services include patient education, access programs, and financial assistance programs.
Overall, Novartis' pharmaceuticals division is dedicated to improving the lives of patients worldwide through innovation, research, and patient-centric services.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page